Kamran Hosseini

982 total citations · 1 hit paper
45 papers, 718 citations indexed

About

Kamran Hosseini is a scholar working on Molecular Biology, Ophthalmology and Pharmacology. According to data from OpenAlex, Kamran Hosseini has authored 45 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Ophthalmology and 9 papers in Pharmacology. Recurrent topics in Kamran Hosseini's work include Ocular Infections and Treatments (7 papers), MicroRNA in disease regulation (5 papers) and Retinal Diseases and Treatments (4 papers). Kamran Hosseini is often cited by papers focused on Ocular Infections and Treatments (7 papers), MicroRNA in disease regulation (5 papers) and Retinal Diseases and Treatments (4 papers). Kamran Hosseini collaborates with scholars based in Iran, United States and China. Kamran Hosseini's co-authors include Vahideh Tarhriz, Parina Asgharian, Tohid Ghasemnejad, Saiedeh Razi Soofiyani, William C. Cho, Javad Sharifi‐Rad, Haleh Forouhandeh, Maryam Ranjbar, Michel Cormier and Daniela Călina and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Kamran Hosseini

42 papers receiving 703 citations

Hit Papers

Potential mechanisms of quercetin in cancer prevention: f... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamran Hosseini Iran 14 292 128 89 69 68 45 718
Tong Li China 19 376 1.3× 178 1.4× 41 0.5× 259 3.8× 43 0.6× 83 1.1k
Madhav Nilakanth Mugale India 18 312 1.1× 52 0.4× 72 0.8× 32 0.5× 10 0.1× 81 748
Guang Xin China 17 440 1.5× 67 0.5× 41 0.5× 23 0.3× 20 0.3× 54 954
Qi Zhou China 20 666 2.3× 48 0.4× 127 1.4× 29 0.4× 40 0.6× 81 1.3k
Lisa Schmölz Germany 13 224 0.8× 72 0.6× 31 0.3× 49 0.7× 214 3.1× 17 688
Yuan Huang China 17 357 1.2× 16 0.1× 117 1.3× 44 0.6× 49 0.7× 55 891
Rajendra Kumar India 20 293 1.0× 23 0.2× 64 0.7× 32 0.5× 27 0.4× 60 1.1k
Jihong Yang China 17 547 1.9× 36 0.3× 47 0.5× 312 4.5× 111 1.6× 48 1.2k
Xiaocui Liu China 18 277 0.9× 51 0.4× 36 0.4× 74 1.1× 29 0.4× 58 1.2k

Countries citing papers authored by Kamran Hosseini

Since Specialization
Citations

This map shows the geographic impact of Kamran Hosseini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamran Hosseini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamran Hosseini more than expected).

Fields of papers citing papers by Kamran Hosseini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamran Hosseini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamran Hosseini. The network helps show where Kamran Hosseini may publish in the future.

Co-authorship network of co-authors of Kamran Hosseini

This figure shows the co-authorship network connecting the top 25 collaborators of Kamran Hosseini. A scholar is included among the top collaborators of Kamran Hosseini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamran Hosseini. Kamran Hosseini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tarhriz, Vahideh, et al.. (2025). CircRNA-based AntimiR therapy: A novel approach to hypertension treatment. Non-coding RNA Research. 13. 94–108. 2 indexed citations
2.
Hosseini, Kamran, Huijing Xia, Ayushi S. Patel, et al.. (2025). Deep learning-driven proteomics analysis for gene annotation in the renin-angiotensin system. European Journal of Pharmacology. 1006. 178119–178119.
3.
Chang, Chao‐Yuan, Kamran Hosseini, Elisabeth Fischer‐Friedrich, et al.. (2024). The F-actin bundler SWAP-70 promotes tumor metastasis. Life Science Alliance. 7(8). e202302307–e202302307. 1 indexed citations
4.
Hosseini, Kamran, et al.. (2023). EMT induces characteristic changes of Rho GTPases and downstream effectors with a mitosis-specific twist. Physical Biology. 20(6). 66001–66001. 1 indexed citations
5.
Hosseini, Kamran, et al.. (2023). Gene therapy approaches for GM1 gangliosidosis: Focus on animal and cellular studies. Cell Biochemistry and Function. 41(8). 1093–1105. 4 indexed citations
6.
Forouhandeh, Haleh, Saiedeh Razi Soofiyani, Kamran Hosseini, et al.. (2023). Modulation of the Immune System Mechanisms using Probiotic Bacteria in Allergic Diseases: Focus on Allergic Retinitis and Food Allergies. PubMed. 18(1). 11–26. 3 indexed citations
7.
Hosseini, Kamran, et al.. (2023). An Investigation into Cell-Free DNA in Different Common Cancers. Molecular Biotechnology. 66(12). 3462–3474. 3 indexed citations
8.
Dilmaghani, Azita, Kamran Hosseini, Vahideh Tarhriz, & Vahid Yousefi. (2023). Synthesis of Zeolitic imidazolate frameworks‐8@ layered double hydroxide polyhedral nanocomposite with designed porous voids as an effective carrier for anti‐cancer drug‐controlled delivery. IET Nanobiotechnology. 17(4). 326–336. 3 indexed citations
9.
Vaez, Haleh, et al.. (2023). Anti-diabetic Effects of Two Species of Eryngium on Streptozotocin-induced Diabetic Mice. Jundishapur Journal of Natural Pharmaceutical Products. 18(1). 1 indexed citations
10.
Asgharian, Parina, Kamran Hosseini, Haleh Forouhandeh, et al.. (2022). Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell International. 22(1). 257–257. 171 indexed citations breakdown →
11.
Asgharian, Parina, Cristina Quispe, Jesús Herrera‐Bravo, et al.. (2022). Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update. Frontiers in Pharmacology. 13. 926607–926607. 24 indexed citations
12.
Hosseini, Kamran, Haleh Forouhandeh, Sepideh Zununi Vahed, et al.. (2022). The role of circadian gene timeless in gastrointestinal cancers. Gene Reports. 30. 101722–101722. 1 indexed citations
13.
Soofiyani, Saiedeh Razi, Kamran Hosseini, Tahereh Ebrahimi, et al.. (2022). Prognostic Value and Biological Role of miR-126 in Breast Cancer. MicroRNA. 11(2). 95–103. 11 indexed citations
14.
Asgharian, Parina, et al.. (2021). Eryngium billardieri Extract and Fractions Induce Apoptosis in Cancerous Cells. Anti-Cancer Agents in Medicinal Chemistry. 22(11). 2189–2201. 10 indexed citations
16.
Hosseini, Kamran, et al.. (2013). Aqueous humor concentration of Bromfenac 0.09% (Bromday) compared with Bromfenac in DuraSite 0.075% (Bromsite) in cataract patients undergoing phacoemulsification after 3 days dosing. Investigative Ophthalmology & Visual Science. 54(15). 5061–5061. 3 indexed citations
17.
Shafiee, Afshin, et al.. (2013). Aqueous Humor Penetration of Ketorolac Formulated in DuraSite or DuraSite 2 Delivery Systems Compared to Acular LS in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 29(9). 812–816. 5 indexed citations
18.
Hosseini, Kamran, et al.. (2013). A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitis. Clinical ophthalmology. 7. 2225–2225. 9 indexed citations
19.
Erwin, C. W., et al.. (2010). Anti-inflammatory Activity of Azithromycin as Measured by Its NF-кB Inhibitory Activity. Ocular Immunology and Inflammation. 18(1). 32–37. 30 indexed citations
20.
Hosseini, Kamran, et al.. (2008). Pharmacokinetic Study of Dexamethasone Disodium Phosphate using Intravitreal, Subconjunctival, and Intravenous Delivery Routes in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 24(3). 301–308. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026